AU7615000A - Vasopressin antagonist formulation and process - Google Patents

Vasopressin antagonist formulation and process Download PDF

Info

Publication number
AU7615000A
AU7615000A AU76150/00A AU7615000A AU7615000A AU 7615000 A AU7615000 A AU 7615000A AU 76150/00 A AU76150/00 A AU 76150/00A AU 7615000 A AU7615000 A AU 7615000A AU 7615000 A AU7615000 A AU 7615000A
Authority
AU
Australia
Prior art keywords
component
pharmaceutical composition
polysorbate
weight
polyethylene glycols
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU76150/00A
Other languages
English (en)
Inventor
Mahdi Bakir Fawzi
Richard William Saunders
Joseph Kyuwung Yoon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of AU7615000A publication Critical patent/AU7615000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU76150/00A 1999-09-27 2000-09-26 Vasopressin antagonist formulation and process Abandoned AU7615000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40577299A 1999-09-27 1999-09-27
US09405772 1999-09-27
PCT/US2000/026369 WO2001022945A1 (en) 1999-09-27 2000-09-26 Vasopressin antagonist formulation and process

Publications (1)

Publication Number Publication Date
AU7615000A true AU7615000A (en) 2001-04-30

Family

ID=23605168

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76150/00A Abandoned AU7615000A (en) 1999-09-27 2000-09-26 Vasopressin antagonist formulation and process

Country Status (18)

Country Link
EP (1) EP1216033A1 (ko)
JP (1) JP2003510269A (ko)
KR (1) KR20020039354A (ko)
CN (1) CN1391466A (ko)
AR (1) AR025780A1 (ko)
AU (1) AU7615000A (ko)
BR (1) BR0014351A (ko)
CA (1) CA2388474A1 (ko)
CZ (1) CZ20021083A3 (ko)
EA (1) EA200200414A1 (ko)
HK (1) HK1045109A1 (ko)
HU (1) HUP0202972A3 (ko)
IL (1) IL148541A0 (ko)
MX (1) MXPA02003189A (ko)
NO (1) NO20021475L (ko)
PL (1) PL354282A1 (ko)
WO (1) WO2001022945A1 (ko)
ZA (1) ZA200203312B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105144A1 (en) * 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
AU2003211267A1 (en) * 2002-02-27 2003-09-09 Shionogi And Co., Ltd. Solid preparations with improved absorbability of hardly water-soluble drug
JP5873375B2 (ja) * 2012-04-03 2016-03-01 中日本カプセル 株式会社 ソフトカプセル及びソフトカプセルの製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516774A (en) * 1993-07-29 1996-05-14 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
CA2318128C (en) * 1998-01-20 2008-10-14 Applied Analytical Industries, Inc. Oral liquid compositions

Also Published As

Publication number Publication date
CZ20021083A3 (cs) 2002-06-12
KR20020039354A (ko) 2002-05-25
CN1391466A (zh) 2003-01-15
NO20021475D0 (no) 2002-03-25
AR025780A1 (es) 2002-12-11
IL148541A0 (en) 2002-09-12
HUP0202972A3 (en) 2003-07-28
EA200200414A1 (ru) 2002-12-26
CA2388474A1 (en) 2001-04-05
NO20021475L (no) 2002-04-16
HK1045109A1 (zh) 2002-11-15
MXPA02003189A (es) 2002-09-30
WO2001022945A1 (en) 2001-04-05
JP2003510269A (ja) 2003-03-18
BR0014351A (pt) 2002-06-11
PL354282A1 (en) 2003-12-29
HUP0202972A2 (hu) 2002-12-28
ZA200203312B (en) 2003-12-31
EP1216033A1 (en) 2002-06-26

Similar Documents

Publication Publication Date Title
US6437006B1 (en) Pharmaceutical carrier formulation
EP1185273B1 (en) Antifungal oral composition containing itraconazole and process for preparing same
US6491950B1 (en) Controlled release pharmaceutical composition
US6221391B1 (en) Self-emulsifying ibuprofen solution and soft gelatin capsule for use therewith
HU225535B1 (en) Microemulsion pre-concentrate and microemulsion
NL193267C (nl) Farmaceutisch preparaat in de vorm van een gelatinecapsule met een vulling die ranitidine-hydrochloride bevat.
JP2006206615A (ja) 経口投与用シクロスポリン含有新規製剤
JPH11512115A (ja) 経口投与用製剤組成物
SK17222001A3 (sk) Farmaceutické prostriedky obsahujúce cyklosporín
JP5750278B2 (ja) カンデサルタンシレキセチルのカプセル充填用組成物
US6352718B1 (en) Vasopressin antagonist formulation and process
SK283216B6 (sk) Prípravok obsahujúci cyklosporín a spôsob jeho prípravy
JP2002511101A (ja) 医薬組成物
AU7615000A (en) Vasopressin antagonist formulation and process
WO2001022942A1 (en) Pharmaceutical carrier formulation
JP2002516280A (ja) 新規医薬組成物
EP3854384A1 (en) Pharmaceutical formulation comprising abiraterone acetate
KR20080038133A (ko) 수면제제의 조절 방출
EP0326103B1 (en) Pharmaceutical composition for 4-aroylimidazol-2-ones
EP3510997B1 (en) Soft gelatin capsules comprising a suspension of tadalafil
JPH04356420A (ja) チアミン・コバルト・クロロフィリン錯化合物含有組成物
SK11352003A3 (sk) Farmaceutický prostriedok
WO2014010008A1 (ja) カンデサルタンシレキセチルのカプセル充填用組成物
KR20050121497A (ko) 이트라코나졸의 경구투여용 조성물 및 그 제조방법

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period